Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 25, 2025 | Arnatar Therapeutics | $52.0M Series A | 3E Bioventures Capital, Eight Roads Ventures | Chuanhua Capital, F-Prime Capital, Gaorong Capital, New Alliance Capital, Yijing Capital |